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Original Article
Impact of invitation schemes on breast
cancer screening coverage: A cohort
study from Copenhagen, Denmark
Katja Kemp Jacobsen1, My von Euler Chelpin1,
Ilse Vejborg2 and Elsebeth Lynge1
Abstract
Background: The purpose of mammography screening is to decrease breast cancer mortality. To achieve this a high coverage
by examination is needed. Within an organized screening programme, we examined the impact of changes in the invitation
schedule on the interplay between coverage and participation.
Method: We studied nine cohorts aged 50–51 when first targeted by mammography screening in Copenhagen, Denmark.
Population data were retrieved from the Danish Civil Registration System; invitation and attendance data from the screening
programme database. Data were linked using unique personal identification numbers. Coverage by invitation was defined as
(number of invited women/number of targeted women), coverage by examination as (number of screened women/number of
targeted women), and participation rate as (number of screened women/number of invited women).
Results: Coverage by invitation was close to or above 95% for all newly recruited cohorts. In subsequent invitation rounds,
both technical errors and changes in the invitation scheme affected the coverage by invitation. Coverage by examination at first
invitation was 72.5% for the first cohort, but dropped to 64.2% for the latest cohort. Furthermore, coverage by examination
dropped by increasing invitation number and with omission of re-invitation of previous non-attenders. Participation rate closely
reflected changes in the invitation scheme.
Conclusion: Changes in the invitation schemes influenced coverage by invitation, coverage by examination, and participation
rate. We observed a considerable gap between coverage by examination and participation rate, strongly indicating that the
latter cannot without reservations, be taken as an indicator of the first.
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Introduction
For mammography screening to reduce breast cancer mor-
tality, a large proportion of the targeted women must be
screened. Monitoring recruitment and participation is an
essential part of the quality assurance of screening. The
European Union recommends organized screening pro-
grammes. Quality indicators for mammography screening
are speciﬁed in the European Guidelines for Quality
Assurance in Breast Cancer Screening and Diagnosis,1
and these include monitoring the coverage of the targeted
population by invitation to screening, the coverage of the
targeted population by screening examination, and the par-
ticipation rate in screening among invited women.
A survey of European mammography screening pro-
grammes showed that coverage by examination varied
from about 30% to about 90%,2 indicating large diﬀer-
ences in the potential impact of screening on breast cancer
mortality. Low coverage by examination in an organized
programme may reﬂect that some targeted women attend
opportunistic screening or it may reﬂect low acceptability
of screening. The organizational aspects of the pro-
gramme very probably also play a role.
We evaluated the eﬀect of variations in the invitation
scheme on coverage and participation through more than
20 years of the organized, population-based mammog-
raphy screening programme in Copenhagen, Denmark.
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Methods
Setting
Organized, population-based mammography screening in
the Copenhagen municipality started on 4th April 1991.
Full descriptions of the programme have been pub-
lished.3,4 The target population was women aged 50–69
residing in the municipality of Copenhagen, identiﬁed
via the daily updated Danish Civil Registration System
(CRS). Over time, various small subgroups were con-
sidered ineligible for screening (see below). Eligible
women were personally invited to screening.
Invitation rounds were of approximately two years
(Appendix Table 2). Invited women received a personal
letter with a ﬁxed, changeable date of appointment. Women
born in January were invited during the ﬁrst two months of
the ﬁrst year of an invitation round, women born in February
were invited during the next two months, etc. Non-responders
received a reminder. Initially, women already diagnosed with
breast cancer and known in the register of the Danish
Collaborative Breast Cancer Group were considered ineligible
and excluded from invitation, but this stopped as it became
clear that the register was not suﬃciently updated for this
purpose. Over time, exclusions encompassed some women
with breast cancer, some with bilateral mastectomy, and
some with breast prostheses prohibiting the mammography
examination. Later, women with breast cancer surgery more
than 18 months ago were again invited for screening. From
the beginning, a woman could notify the clinic if she did not
want to be invited again, in which case she did not receive any
further invitation (Appendix Table 3).
In invitation rounds 1–7, women aged 50–69 at the
start of each round were invited (Figure 1). In invitation
round 2, women aged 50–71 at the start were invited. All
women were invited to the next round, except those who
had notiﬁed the programme not to be re-invited, moved
out of the area, or passed the upper age limit for re-invita-
tion. In invitation rounds 6 and 7, approximately 10% of
the target population were not invited due to unidentiﬁed
technical errors in the invitation system.5
From invitation round 8 onwards, invitations were
planned to be issued according to attained age, meaning
that women aged 50–69 at the invitation date were invited
to screening. Women received the ﬁrst invitation at age
50–51 and the last at age 68–69, depending on age at ﬁrst
invitation. Exceptionally for round 8, invitations included
all women from the age of 48 at the start of round 8. For
invitation round 8, part of non-participants from round 7,
including those not invited due to technical errors, were
not invited. Women previously administratively excluded
due to technical errors were re-invited in invitation round
9. However, in invitation rounds 9 and 10, women who
had not responded to the previous two invitation rounds
(previous passive non-participants) were not invited.
Data
CRS holds information on current and historical addresses
for residents in Denmark since 1968. From the CRS, we
identiﬁed the target population of the Copenhagen muni-
cipality screening programme from 1 April 1991 to
12 July 2012, covering 10 biennial invitation rounds.
Figure 1. Cohorts of women first targeted by the Copenhagen programme at age 50–51 by age, invitation rounds, and invitation numbers
(marked in graph).
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From invitation rounds 1–8, the Copenhagen screening
programme kept a mammography register with the per-
sonal identiﬁcation number (including information on
and date of birth), date of invitation, dates of reminders,
date of screening, outcome of screening, and (where rele-
vant) dates and outcome of assessment and surgery. The
register also included information on women who had noti-
ﬁed the programme that they did not want to be invited,
and the register included codes for ineligibility. From invi-
tation round 9 onwards, the Copenhagen programme
became incorporated into the larger programme for the
Capital Region of Denmark. The structure of the mam-
mography screening register for the Capital Region diﬀers
from the old register from Copenhagen. However, it is pos-
sible from this new register to obtain the same information
as before, apart from ineligibility, for which only the latest
registration was kept in the new register. We linked the data
retrieved from the CRS and the screening registers, which
provided us with a complete invitation history of all tar-
geted women. The use of opportunistic screening has
always been very limited in Denmark.6
Analysis
To control for age and number of oﬀered screens when we
compared coverage with participation, we constructed
nine closed cohorts, each including women aged 50–51
at the start of their ﬁrst invitation round (cohort 1–9).
These cohorts were followed up from the ﬁrst through
subsequent invitation rounds (1–10, 1–9,. . . 1–2), each
time including those present from the cohort at the start
of a given round. We used the term ‘invitation number’ for
the ﬁrst, second, etc. number of times a given cohort had
been oﬀered screening. For study design and birth dates
for cohorts, see Figure 1.
Each cohort was tabulated by number of women targeted,
number of women invited, and number of women participat-
ing by invitation round and invitation number. We were not
able to tabulate the number of eligible women for invitation
rounds 9–10, as only the latest ineligibility code was kept in
the system. We also calculated coverage by invitation
(number of invited women divided by number of women in
the target population), coverage by examination (number of
participating women divided by number of women in the
target population), and participation rate (number of parti-
cipating women divided by number of invited women) by
invitation round and invitation number.
The change in invitation scheme in round 8 to include
all women from age 48 onwards meant that our cohort 9
started with the second invitation number.
Results
Our study included 47,990 screen targeted women, of
whom 45,597 were invited; of these, 31,424 participated
in screening (Appendix Table 4).
Coverage by invitation for the newly recruited cohorts
of women aged 50–51 was close to 95% in all invitation
rounds except round 2, where it reached 99.5%, and
round 7 where it dropped to 93.7% (Table 1). For
cohort 1, coverage by invitation dropped gradually over
successive invitation numbers, from 95.6% at ﬁrst invita-
tion to 87.4% at ﬁfth invitation. A dramatic drop to
70.0% at invitation 6 was observed, remaining low at invi-
tations 7 and 8 and then increasing again to 76.6% at
invitation 9. Similar changes were seen for cohort 2 at
invitations 5 and 8, respectively, and for cohort 3 at invi-
tations 4 and 7, respectively, and so forth for successive
cohorts. These dramatic drops in coverage by invitation
reﬂected the errors in the invitation scheme in invitation
rounds 6–8, and the equally dramatic increases reﬂected
the deletion of previous administrative exclusions in invi-
tation round 9. The low number for cohort 1 invitation 10
(17.1%) reﬂected that women were no longer invited when
they turned 70.
Coverage by examination for the newly recruited
women was 72.5% for cohort 1, but dropped below
70% for cohort 3 onwards, and was 64.2% for cohort 8.
For cohorts 1–4, coverage by examination dropped by
increasing invitation number, for cohort 1 from 72.5%
at invitation 1 to 52.4% at invitation 9 (Table 1 and
Figure 2). Cohorts 5–8 started out with a lower cover-
age by examination (around 63%) than the previous
cohorts, but tended to maintain this level through the
next 3–4 invitations. Two changes in the invitation
scheme aﬀected invitation rounds 9 and 10. First, previous
administrative exclusions due to technical errors were
deleted. Second, women not participating in the previous
two rounds were not invited. These changes did not
clearly aﬀect the coverage by examination in the earliest
cohorts, probably because these old cohorts would have
accumulated many technical errors, and the deletion of
these errors would tend to increase coverage by examin-
ation, and because the omitting to invite those not attend-
ing the last two times would tend to decrease coverage
by examination. However, in cohorts 5–8, where less
technical errors were accumulated, omitting to invite
women not attending the last two times clearly
resulted in a decrease in coverage by examination, e.g.
from 63.8 to 60.8%/58.5% in cohort 6. In cohort 8,
this change would be expected only in invitation 3,
which was also the case.
Participation rate at ﬁrst invitation number was 75.9%
for cohort 1, but dropped below 70% from cohort 5
onwards, reaching 67.2% for cohort 8 (Table 1). For
cohort 1, the dramatic changes in coverage by invitation
across invitation number were reﬂected in opposite dra-
matic changes in the participation rate, increasing from
70.6% at invitation 5 to 84.8% at invitation 6 and then
dropping again to 68.4% at invitation 9. Similar patterns
were seen for the other cohorts. While the changes due to
the errors in the invitation scheme during invitation
rounds 6–8 became less visible in the participation rates
for the later cohorts, the drop in coverage by invitation
during invitations rounds 9 and 10 was clearly reﬂected in
increased participation rates.
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The interplay between coverage by examination and
participation rate is illustrated in Figure 3. The ﬁgure
clearly shows the gap that developed between the two
measures after invitation 5.
Discussion
This study demonstrates the impact of the invitation
scheme on the European Union quality indicators for
mammography screening. We had four important obser-
vations. First, the participation rate in an organized mam-
mography screening programme seemed highly dependent
on the invitation scheme, with about a 20% increase (e.g.
invitation 4 from 67.6 to 84.1%/79.8%) when invitations
were restricted to those who participated in the previous
round. Second, coverage by examination seemed to
decrease by between 8 and 16% with increasing invitation
number over seven invitation rounds (e.g. cohort 4 from
67.1 to 58.0%). Third, for the latest recruited cohorts the
coverage by examination tended to drop by 5–10% when
non-attenders from the previous round were not re-invited
(e.g. cohort 6 from 63.8 to 60.8%/58.5%). This change
was less visible in the earlier recruited cohorts, where it
was balanced out by simultaneous deletion of old tech-
nical errors. Fourth, over time the participation rate
became an increasingly bad indicator of coverage by
examination (e.g. cohort 1 showing a gap from 68.4 to
52.4% at invitation 9).
Our study had several strengths. Because the CRS
tracks all residents in Denmark, we could on each starting
date of an invitation round identify the closed cohort of
women aged 50–51 and living in the municipality of
Copenhagen. All invitations and participations were rec-
orded in the programme registers. Linkage between CRS
and screening registers was based on the unique personal
identiﬁcation numbers, so we could accurately identify the
target population, the invited women, and the participat-
ing women. Many studies have documented the impact of
the information approach on the participation in screen-
ing.7–10 It is a further strength of our study that
Figure 2. Average coverage by examination (%) for cohorts of women first targeted by the Copenhagen programme age 50–51 by invitation
number and invitation round.
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throughout the entire study period, invited women
received a personal invitation letter with a ﬁxed, change-
able date of appointment.
A limitation in the study was that because the latest
ineligibility code was not kept in the system for invitation
rounds 9–10, it was not possible to separate out the impact
of changes in ineligibility criteria from the impact of errors
in the invitation data. However, the only quantitatively
important change in ineligibility was probably the increase
in coverage by invitation from 95.6% in invitation round
1 to 99.5% in invitation round 2, when the linkage with
the register of the Danish Breast Cancer Cooperative
Group stopped. In invitations rounds 1–7, some women
could be 53 before their ﬁrst invitation. The new invitation
scheme by attained age was introduced to remedy this
problem. For that reason, in invitation rounds 8–10
women turning 50 before their birth cohort had been
invited were invited in the current round. In invitation
round 10, those turning 70 during the round were invited
in total only nine times. To take account of this, from
invitation round 11 onwards, all women are now invited
before they turn 70.
Based on our results it might be expected that a high
coverage by invitation would be associated with a low
participation rate, however such an association could
not be found in the survey data from 25 European screen-
ing programmes.2 Both coverage by invitation and partici-
pation rate can be aﬀected by local factors, complicating
comparison across European countries.
For mammography screening to decrease breast cancer
mortality in the targeted population, coverage by examin-
ation must be high.1,11 Breast cancer mortality in the target
Table 1. Coverage by invitation (%), coverage by participation (%), and participation rates (%) by invitation rounds and invitation numbers
for women first targeted by the Copenhagen screening programme at age 50–51.
Invitation round, first targeted¼ cohort number
Invitation number
1 2 3 4 5 6 7 8 9 10
Coverage by invitation (%)
1 95.6 93.7 90.4 88.3 87.4 70.0 68.0 67.8 76.6 17.1
2 99.5 91.8 89.4 88.5 68.9 67.7 68.0 80.0 78.1
3 95.9 93.5 92.3 72.2 70.0 69.1 82.0 79.0
4 95.6 93.4 78.1 76.3 74.6 78.9 76.6
5 94.9 92.8 89.7 84.8 70.8 68.4
6 96.0 91.7 90.9 72.3 70.7
7 93.7 91.7 75.3 72.6
8 95.4 91.0 88.5
9 NR 89.2 87.1
Coverage by examination (%)
1 72.5 66.0 65.6 63.9 61.7 59.3 56.6 56.5 52.4 11.1
2 70.4 64.1 62.9 60.0 57.4 57.1 57.5 57.3 54.5
3 66.5 63.5 60.7 58.8 57.6 57.8 59.0 57.4
4 67.1 62.3 60.7 59.8 60.8 60.9 58.0
5 63.9 61.4 62.5 63.2 59.6 56.6
6 62.7 63.0 63.8 60.8 58.5
7 63.0 62.1 59.9 57.9
8 64.2 63.1 59.1
9 NR 60.6 58.9
Participation rate (%)
1 75.9 70.4 72.5 72.3 70.6 84.8 83.3 83.4 68.4 64.9
2 70.7 69.9 70.3 67.6 83.3 84.3 84.6 71.6 69.8
3 69.3 67.9 65.7 81.4 82.3 83.6 72.0 72.7
4 70.2 66.7 77.7 78.4 81.6 77.1 75.7
5 67.4 66.1 69.7 74.5 84.2 82.9
6 65.3 68.7 70.2 84.1 82.8
7 67.2 67.8 79.6 79.8
8 67.2 69.3 66.8
9 NR 68.4 68.0
: invitation round 1–5.
24 Journal of Medical Screening 24(1)
population of the Copenhagen programme decreased by
25% during the ﬁrst 10 years after the programme
started.12 These results derived from the early recruited
cohorts starting out with a coverage by examination of
67–73%. However, the cohorts recruited later started out
with a coverage by examination of 63–64%, a drop
expected to have an impact on the outcome of screening
at the population level. During the ﬁrst 10 years of the
Copenhagen programme, breast cancer mortality in
screened women dropped by 37%, and this eﬀect is
expected to be seen also in screened women from later
recruited cohorts.
The slight drop in coverage by examination following
the cessation of re-invitation of non-attenders was seen for
the later, but not the earlier cohorts, probably due to the
coinciding deletions of technical errors. The drop is a
matter of concern, especially because the later cohorts
already had a lower coverage by examination at ﬁrst invi-
tation than previous cohorts. In 2015, the Copenhagen
programme went back to the previous procedure and
now re-invites all women except those who actively
opted out. We will thus never get long-term data from
Copenhagen on the impact of the limited invitation
scheme. Nevertheless, our data can serve as a warning
for other programmes that for logistical reasons want to
limit invitations to previous attenders.
The European Guidelines1 use coverage by invitation,
coverage by examination, and participation rate as quality
indicators, but acceptable and desirable levels of achieve-
ment are given only for the participation rate (70 and
75%, respectively). There are good reasons for this limita-
tion, as the participation rate can normally be calculated
from the screening programme data alone, while the two
other measures require access to accurate and updated popu-
lation data. Our study nevertheless demonstrated that the
participation rate can be considerably higher than the cover-
age by examination. Unless limitations in the invitation
scheme are taken into account, health authorities focusing
on the participation rate may expect their target population
to be better protected against death from breast cancer by a
screening programme than is actually the case.
Our study demonstrates the complexity of measuring
even simple quality indicators, such as coverage by invi-
tation, coverage by examination, and participation rate.
Part of this complexity may be derived from errors in the
invitation scheme in the Copenhagen programme, but
Denmark has better population registers than almost all
other screening settings, and it is unlikely that errors such
as those in the Copenhagen programme would not also
occur in other programmes. The diﬀerence may be that
the quality of the Danish registers allowed the impact of
such errors to be documented.
Figure 3. Coverage by examination (%) and participation rate (%) for cohorts of women first targeted by the Copenhagen programme age
50–51 by invitation number.
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Conclusion
Our study demonstrates that coverage by examination
tended to decrease over successive rounds of a mammog-
raphy screening programme. The participation rate was
highly sensitive to changes in the invitation scheme,
increasing considerably when previous non-attenders
were not re-invited. We observed a considerable gap
between the coverage of examination and the participa-
tion rate, strongly indicating that the latter cannot, with-
out reservations, be taken as an indicator of the former.
Health care administrators should be aware of this inter-
play between the quality indicators, in order to avoid that
interpretation that the participation rate is a direct reﬂec-
tion of the coverage by examination.
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